Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Freemantle

Showing results (11-20 of 420) with videos related to

Pageof 42
Sort By:
Psychopharmacology|May 28, 2008
The review by Weinmann and colleaguesNick Freemantle
Journal of Clinical Epidemiology|November 3, 2009
Real-world effectiveness of new medicines should be evaluated by appropriately designed clinical trialsNick Freemantle, Thomas Strack
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 23, 2018
Randomized trials and propensity score analyses in transcatheter aortic valve replacement: how should we interpret the results?Nick Freemantle, Domenico Pagano
BMJ (Clinical Research Ed.)|May 1, 2014
Trials of autologous bone marrow stem cells for heart diseaseNick Freemantle, Greta Rait
Lancet (London, England)|September 15, 2018
Interpretation of results of pooled analysis of individual patient dataNick Freemantle, Domenico Pagano
European Journal of Heart Failure|August 11, 2004
Answering important questions reliably--GISSI Heart Failure, a factorially designed trial with composite (co)primary outcome measuresNick Freemantle, Melanie Calvert
BMJ (Clinical Research Ed.)|April 16, 2002
Medicalisation, limits to medicine, or never enough money to go around?Nick Freemantle, Suzanne Hill
Pharmacoeconomics|January 31, 2009
The applicability and generalizability of findings from clinical trials for health-policy decisionsNick Freemantle, Franz Hessel
BMJ (Clinical Research Ed.)|November 20, 2023
Will the ROB-ME checklist prevent omission bias in meta-analyses?Nick Freemantle, Alar Irs
The Journal of Thoracic and Cardiovascular Surgery|August 20, 2013
Reply to the editorDomenico Pagano, Nick Freemantle
Pageof 42

Showing results (11-20 of 420) with videos related to

Sort By:
Pageof 42
Psychopharmacology|May 28, 2008
The review by Weinmann and colleaguesNick Freemantle
Journal of Clinical Epidemiology|November 3, 2009
Real-world effectiveness of new medicines should be evaluated by appropriately designed clinical trialsNick Freemantle, Thomas Strack
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 23, 2018
Randomized trials and propensity score analyses in transcatheter aortic valve replacement: how should we interpret the results?Nick Freemantle, Domenico Pagano
BMJ (Clinical Research Ed.)|May 1, 2014
Trials of autologous bone marrow stem cells for heart diseaseNick Freemantle, Greta Rait
Lancet (London, England)|September 15, 2018
Interpretation of results of pooled analysis of individual patient dataNick Freemantle, Domenico Pagano
European Journal of Heart Failure|August 11, 2004
Answering important questions reliably--GISSI Heart Failure, a factorially designed trial with composite (co)primary outcome measuresNick Freemantle, Melanie Calvert
BMJ (Clinical Research Ed.)|April 16, 2002
Medicalisation, limits to medicine, or never enough money to go around?Nick Freemantle, Suzanne Hill
Pharmacoeconomics|January 31, 2009
The applicability and generalizability of findings from clinical trials for health-policy decisionsNick Freemantle, Franz Hessel
BMJ (Clinical Research Ed.)|November 20, 2023
Will the ROB-ME checklist prevent omission bias in meta-analyses?Nick Freemantle, Alar Irs
The Journal of Thoracic and Cardiovascular Surgery|August 20, 2013
Reply to the editorDomenico Pagano, Nick Freemantle
Pageof 42